fasentin,
N-(4-chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide,
Fasentin,
392721-37-8,
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxobutanamide,
Glucose Transporter Inhibitor,
N-(4-Chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide,
AC1LGZUC,
CBMicro_009435,
AC1Q1K2J,
SCHEMBL2350751,
Fasentin, >=98% (HPLC),
CTK7G4986,
DTXSID60358175,
ZINC449608,
SMSF0013818,
MFCD01001285,
AKOS000166407,
CB12214,
MCULE-9795460928,
NCGC00485097-01,
BIM-0009515.P001,
RT-012698,
ST51005182,
EN300-53607,
W-7776,
SR-01000227427,
SR-01000227427-1,
CID879520,
ZINC00449608,
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-butanamide,